Advertisement
Journal Home
Search for

Volume 73, Issue 12, Pages 1639-1643 (December 2009)


View previous. 7 of 48 View next.

l-Epinephrine and dexamethasone in postextubation airway obstruction: A prospective, randomized, double-blind placebo-controlled study

Regina Grigolli CesaraCorresponding Author Informationemail address, Werther Brunow de Carvalhob

Received 22 April 2009; received in revised form 4 August 2009; accepted 7 August 2009.

Abstract 

Purpose

This prospective randomized double-blind placebo-controlled study paired trial groups to investigate the effect of intravenous dexamethasone and nebulized l-epinephrine on the clinical development of postextubation laryngeal edema.

Material and methods

Sixty-four patients aged 1 day to 12 years who needed intubation from August/1997 to February/1999 in the Pediatric Intensive Care Unit (PICU) of Santa Casa de São Paulo School of Medicine were paired according to age, height and weight, anthropometric z-scores, duration of tracheal intubation and number of intubation attempts. Patients received intravenous dexamethasone (0.2mg/kg every 6h), with or without nebulized l-epinephrine (0.5mg/kg every 4h) in the study groups; in the control groups, they received nebulized or intravenous isotonic saline solution, or both. Dependent variables: frequency and severity of the laryngeal edema (according to Westley Clinical Scoring System), as well as the time interval (min) between extubation and the first postextubation laryngeal edema scores. Postextubation respiratory rate and transcutaneous oxygen saturation were employed as indicators of the clinical conditions for extubation.

Results

Laryngeal edema frequencies did not change according to treatments, χ2 (3, N=64)=0.58, p>0.05, and the highest scores were not reached in the 24h after extubation, (3, N=16)=1.03, p>0.05.

Conclusions

Dexamethasone and l-epinephrine did not reduce the clinical progression of airway obstruction due to laryngeal edema in the early postextubation period.

a Pediatric Intensive Care Unit, Department of the Santa Casa de São Paulo, School of Medicine, Rua Marcilio Dias, 104, Lapa, CEP: 05077-120 São Paulo (SP), Brazil

b Universidade Federal de São Paulo-Escola Paulista de Medicina (UNIFESP), São Paulo (SP), Brazil

Corresponding Author InformationCorresponding author. Tel.: +55 11 38347634.

PII: S0165-5876(09)00420-0

doi:10.1016/j.ijporl.2009.08.004


View previous. 7 of 48 View next.

Advertisement